Literature DB >> 20852367

Costs of hemodialysis and kidney transplantation in Sudan: a single center experience.

Mohamed Elhafiz Elsharif1, Elham Gariballa Elsharif, Waheeb Hassan Gadour.   

Abstract

INTRODUCTION. End-stage renal disease is a serious illness with major consequences in both health and healthcare expenditures. The growing number of patients with end-stage renal disease in developing countries will consume a greater proportion of healthcare budget. We aimed to assess the costs of hemodialysis and kidney transplantation in a renal care center in Sudan. MATERIALS AND METHODS. We conducted a cross-sectional study to estimate the costs of kidney transplantation and compare those with the costs of hemodialysis per year. We enrolled 78 patients on regular hemodialysis for at least 2 years and 33 kidney transplant patients on regular follow-up at Gezira Hospital for Renal Diseases and Surgery in Sudan. RESULTS. The annual cost of hemodialysis was found to be US $ 6847.00. The total cost of the first year after transplantation was US $ 14 825.04 and the cost of kidney transplantation after the first year was US $ 10 651.00. The total hospitalization days and absence from work were less in the transplant group. Conclusions. Hemodialysis in Sudan is less expensive than transplantation.

Entities:  

Mesh:

Year:  2010        PMID: 20852367

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  10 in total

1.  Cost of Hemodialysis Treatment and Associated Factors Among End-Stage Renal Disease Patients at the Tertiary Hospitals of Addis Ababa City and Amhara Region, Ethiopia.

Authors:  Daniel Asrat Kassa; Solomon Mekonnen; Adane Kebede; Tsegaye Gebremedhin Haile
Journal:  Clinicoecon Outcomes Res       Date:  2020-07-27

2.  The costs in provision of haemodialysis in a developing country: a multi-centered study.

Authors:  Priyanga Ranasinghe; Yashasvi S Perera; Mohamed F M Makarim; Aruna Wijesinghe; Kamani Wanigasuriya
Journal:  BMC Nephrol       Date:  2011-09-06       Impact factor: 2.388

3.  Economic evaluation of end stage renal disease patients undergoing hemodialysis.

Authors:  A Suja; R Anju; V Anju; J Neethu; P Peeyush; R Saraswathy
Journal:  J Pharm Bioallied Sci       Date:  2012-04

Review 4.  Economic Evaluation of Pharmacogenetic Tests in Patients Subjected to Renal Transplantation: A Review of Literature.

Authors:  Nemanja Rancic; Viktorija Dragojevic-Simic; Neven Vavic; Aleksandra Kovacevic; Zoran Segrt; Natasa Djordjevic
Journal:  Front Public Health       Date:  2016-08-31

5.  A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa.

Authors:  Letlhogonolo Makhele; Moliehi Matlala; Mncengeli Sibanda; Antony P Martin; Brian Godman
Journal:  Pharmacoecon Open       Date:  2019-12

Review 6.  Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review.

Authors:  Elizabeth D Brouwer; David Watkins; Zachary Olson; Jane Goett; Rachel Nugent; Carol Levin
Journal:  BMC Public Health       Date:  2015-11-26       Impact factor: 3.295

Review 7.  The cost of dialysis in low and middle-income countries: a systematic review.

Authors:  Lawrencia Mushi; Paul Marschall; Steffen Fleßa
Journal:  BMC Health Serv Res       Date:  2015-11-12       Impact factor: 2.655

8.  Cost-effectiveness analysis of dialysis and kidney transplant in patients with renal impairment using disability adjusted life years in Iran.

Authors:  Safiye YaghoubiFard; Reza Goudarzi; Abbas Etminan; MohammadReza Baneshi; Mohsen Barouni; Mohammad Jafari Sirizi
Journal:  Med J Islam Repub Iran       Date:  2016-06-28

9.  Challenges and outcomes of haemodialysis among patients presenting with kidney diseases in Dodoma, Tanzania.

Authors:  Alfred J Meremo; David P Ngilangwa; Masumbuko Y Mwashambwa; Matobogolo B Masalu; Janet Kapinga; Rehema Tagalile; Issa Sabi
Journal:  BMC Nephrol       Date:  2017-07-04       Impact factor: 2.388

10.  A cost analysis of kidney replacement therapy options in Palestine.

Authors:  Mustafa Younis; Samer Jabr; Abdallah Al-Khatib; Dana Forgione; Michael Hartmann; Adnan Kisa
Journal:  Inquiry       Date:  2015-03-11       Impact factor: 1.730

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.